Fe 3 O 4 @L‐lysine‐Pd(0) organic–inorganic hybrid: As a novel heterogeneous magnetic nanocatalyst for chemo and homoselective [2 + 3] cycloaddition synthesis of 5‐substituted 1H‐tetrazoles

A new samarium complex of 1,3-bis(pyridin-3-ylmethyl)thiourea on boehmite nanoparticles as a practical and recyclable nanocatalyst for the selective synthesis of tetrazoles

Boehmite is a natural and environmentally friendly compound. Herein boehmite nanoparticles were primarily synthesized and, then, their surface were modified via 3-choloropropyltrimtoxysilane (CPTMS). Afterwards, a new samarium complex was stabilized on the surface of the modified boehmite nanoparticles (Sm-bis(PYT)@boehmite). The obtained nanoparticles were characterized using thermogravimetric analysis (TGA), energy dispersive X-ray spectroscopy (EDS), Brunauer-Emmett-Teller (BET), wavelength dispersive X-ray spectroscopy (WDX), scanning electron microscope (SEM), Fourier transform infrared spectroscopy (FT-IR), Inductively coupled plasma mass spectrometry (ICP-MS), dynamic light scattering (DLS), and X-ray diffraction (XRD) pattern. Sm-bis(PYT)@boehmite was used as an environmentally friendly, efficient, and organic-inorganic hybrid nanocatalyst in the homoselective synthesis of tetrazoles in polyethylene glycol 400 (PEG-400) as a green solvent. Notably, Sm-bis(PYT)@boehmite is stable and has a heterogeneous nature. Thus, it can be reused for several runs without any re-activation.

Tetrazole: A privileged scaffold for the discovery of anti-cancer agents

Carcinoma, characterized by abnormal growth of cells and tissue, is a ubiquitously leading cause of mortality across the globe due to some carcinogenic factors. Currently, several anticancer agents are commercially available in the global market. However, due to their resistance and cost, researchers are gaining more interest in developing newer novel potential anticancer agents. In the search for new drugs for clinical use, the tetrazole ring system has emerged as an exciting prospect in the optimization studies of promising lead molecules. Among the various heterocyclic agents, tetrazole-containing compounds have shown significant promise in the treatment of a wide range of diseases, particularly cancer. Here, in this review, we focused on several synthetic approaches for the synthesis of tetrazole analogues, their targets for treating cancer along with the biological activity of some of the recently reported tetrazole-containing anticancer agents.